Business Description
Peak Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US70470P1084
Description
Peak Bio Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing unmet needs in the areas of oncology and inflammation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -10.76 | |||||
| Debt-to-Equity | -0.44 | |||||
| Debt-to-EBITDA | -0.36 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -86.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.93 | |||||
| 9-Day RSI | 92.66 | |||||
| 14-Day RSI | 62.35 | |||||
| 6-1 Month Momentum % | -95.64 | |||||
| 12-1 Month Momentum % | -99.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4754.21 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2794.41 | |||||
| Net Margin % | -4288.65 | |||||
| FCF Margin % | -1293.09 | |||||
| ROE % | -755.25 | |||||
| ROA % | -149.02 | |||||
| ROIC % | -73.9 | |||||
| ROC (Joel Greenblatt) % | -1557.17 | |||||
| ROCE % | -422.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.27 | |||||
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.36 | |||||
| EV-to-Revenue | 13.92 | |||||
| EV-to-FCF | -1.08 | |||||
| Earnings Yield (Greenblatt) % | -277.78 | |||||
| FCF Yield % | -4137.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PKBO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Peak Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.608 | ||
| EPS (TTM) ($) | -1.306 | ||
| Beta | 0 | ||
| Volatility % | 343.32 | ||
| 14-Day RSI | 62.35 | ||
| 14-Day ATR ($) | 0.000509 | ||
| 20-Day SMA ($) | 0.005695 | ||
| 12-1 Month Momentum % | -99.22 | ||
| 52-Week Range ($) | 0.002 - 1 | ||
| Shares Outstanding (Mil) | 22.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Peak Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Peak Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Peak Bio Inc Frequently Asked Questions
What is Peak Bio Inc(PKBO)'s stock price today?
The current price of PKBO is $0.01. The 52 week high of PKBO is $1.00 and 52 week low is $0.00.
When is next earnings date of Peak Bio Inc(PKBO)?
The next earnings date of Peak Bio Inc(PKBO) is .
Does Peak Bio Inc(PKBO) pay dividends? If so, how much?
Peak Bio Inc(PKBO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers